211109 WSJ &

Wall Street Balks at SEC Policy Push

(리테일 브로커리지 회사가 고객 주문정보를 시장조성자한테 매각하는 사업구조 혹은 방식에 대해 SEC 의장이  

관련 사항을 조사해보라 시켰고, 업계는 로비를 통해 이를 저지하려는중. 미국이라 가능한 이야기고 로비가 실패한다면

어떻게 될지 궁금하다)

 

Public Health Still is Big Near-Term Risk

The potential for U.S. public health to worsen as the Covid-19 pandemic continues is one of the greatest near-term risks to the financial system, the Federal Reserve said, while noting that asset prices are susceptible to large declines 

should investor sentiment shift. Any deterioration in public health could slow the recent economic recovery,  particularly if widespread business closures returned and supply chains were further disrupted, the Fed said.

 

Asset prices may be vulnerable to significant declines should risk appetite fall, progress on containing the virus disappoint, or the recovery stall,” the central bank said in its semiannual Financial Stability Report.

 

Treatment Cut Covid Risk, Says Regeneron

Regeneron Pharmaceuticals Inc. said its monoclonal antibody drug continued to provide strong protection against Covid-19 infection for eight months, reducing the risk of contracting the disease by 81.6% compared withaplacebo in a long-term study. Regeneron said Monday that the data show the drug, called REGEN-COV, can provide longlasting temporary immunity against Covid-19, which could make it an attractive option for people who don’t respond to vaccines because they have impaired immune systems.

 

German Covid-19 Cases Set Record

Infections are rising again in Europe, as colder temperatures and the fading of vaccine-induced immunity drive renewed case loads.